Ørsted (ORSTED) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
5 Nov, 2026Executive summary
Q3 EBITDA excluding new partnerships and cancellation fees was DKK 5.26bn, up 72% YoY; reported net profit was -DKK 0.7bn, including DKK 3.4bn of non-cash impairments.
9M EBITDA on the same basis reached DKK 20.24bn, up 19% YoY; renewable generation rose 13% to 27.7 TWh.
Borkum Riffgrund 3 and Revolution Wind entered commercial operation; 6.5 GW of offshore capacity remained under construction.
Financial highlights
Q3 revenue increased 73% YoY to DKK 21.2bn; Q3 EBITDA was DKK 5.26bn vs. DKK 3.06bn.
9M revenue rose 39% to DKK 69.5bn; EBIT was DKK 6.78bn vs. DKK 9.66bn, and profit for the period was DKK 2.6bn vs. DKK 6.5bn.
Adjusted Q3 net profit was DKK 2.2bn vs. -DKK 0.4bn, excluding impairments, new partnerships and cancellation fees.
9M operating cash flow was DKK 7.97bn vs. DKK 6.65bn; gross investments were DKK 28.53bn vs. DKK 39.92bn.
Outlook and guidance
FY 2026 EBITDA guidance, excluding new partnership agreements and cancellation fees, remains above DKK 28bn, assuming normal wind speeds for the rest of the year.
FY 2026 gross investments are expected at DKK 45–50bn, DKK 5bn below prior guidance due to payment timing; total project investment is unchanged.
2027 EBITDA target is above DKK 32bn; average adjusted ROCE is expected at -11% in 2026–2027 and above 13% in 2028–2030.
Directional earnings guidance versus 2025 is higher for Offshore, in line for Onshore, and lower for Bioenergy & Other.
Latest events from Ørsted
- Adjusted EBITDA beat guidance as the reset plan prioritizes value-led growth and balance-sheet resilience.ORSTED
Q4 2023 (Media) - 2023 EBITDA guidance of DKK 20bn–23bn rests on renewable recovery amid hedge and project risks.ORSTED
Guidance - Portfolio reset targets 35–38 GW of renewables by 2030 with tighter risk controls.ORSTED
Q4 2023 & Capital Markets Update - FY 2026 EBITDA guidance tops DKK 28bn as higher US rates raise impairment sensitivity.ORSTED
Pre-Close Call Presentation - H1 2026 EBITDA up, revenue rises 28%, profit drops on impairments; 2026 outlook reaffirmed.ORSTED
Q2 2026 - EBITDA set to exceed DKK 28 bn in 2026, with major divestments and improved ROCE outlook.ORSTED
Pre-Close Call Presentation - EBITDA to surpass DKK 28 bn in 2026, with major investments and US-driven impairments.ORSTED
Pre-Close Call Presentation - Key AGM resolutions passed; offshore wind strategy continued amid U.S. delays.ORSTED
AGM 2026 - Value-focused refocus, U.S. impairments and no FY2024 dividend; key AGM items approved.ORSTED
AGM 2025